Stock Events

Stock Events

Eurofins Cerep 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

11.67%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
40.98MRevenue
4.78MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
IQVIA
IQV
Mkt Cap44.06B
IQVIA Holdings provides advanced analytics, technology solutions, and contract research services, directly competing in the pharmaceutical and biotech outsourcing space.
Charles River Laboratories International
CRL
Mkt Cap17.16B
Charles River Laboratories offers a variety of preclinical and clinical laboratory services for the pharmaceutical, medical device, and biotechnology industries, similar to Eurofins Cerep.
Icon Energy
ICON
Mkt Cap3.73M
ICON plc is a global provider of outsourced development and commercialisation services to pharmaceutical, biotechnology, and medical device industries, competing in clinical research and development.
Waters
WAT
Mkt Cap45.46B
Waters Corporation produces analytical standards and reagents, instrumentation, and software, serving the life sciences market similarly to Eurofins Cerep.
Mettler-Toledo International
MTD
Mkt Cap33.56B
Mettler-Toledo International offers precision instruments and services for use in laboratories, competing in the lab services and instrumentation sector.
Bruker
BRKR
Mkt Cap8.7B
Bruker Corporation designs and manufactures scientific instruments and analytical and diagnostic solutions, serving similar research and development markets.
Thermo Fisher Scientific
TMO
Mkt Cap257.71B
Thermo Fisher Scientific is a major supplier of scientific instrumentation, reagents and consumables, and software services, competing across multiple areas of the life sciences industry.
Agilent Technologies
A
Mkt Cap49.3B
Agilent Technologies provides instruments, services, consumables, applications, and expertise, focusing on life sciences and laboratory management similar to Eurofins Cerep.

About

Established in 1989 and headquartered in Vienne, France, Eurofins Cerep SA delivers a broad spectrum of drug discovery support to pharmaceutical and biotechnology enterprises across the globe. The company's specialized offerings include the management of chemical compounds, high-throughput screening capabilities, in vitro safety assessments, optimization of lead compounds (SAR profiling), in vitro ADME evaluations, and in vivo pharmacokinetic (PK) studies. Furthermore, it provides expert services in assay development and design. The organization, originally known as Cerep SA, officially adopted the name Eurofins Cerep SA in June 2014.
Show More
CEO
Damien Vielliard
Employees
209
Country
France
ISIN
FR0012413771

Listings

MU
DE
ZEP1.MU
PA
FR
ALECR.PA
MU
DE
ZEP2.MU

0 Comments

Share your thoughts

FAQs

What is Eurofins Cerep stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Eurofins Cerep stocks are traded under the ticker ZEP1.MU.
What is Eurofins Cerep revenue for the last year?▼
Eurofins Cerep revenue for the last year amounts to 40.98M EUR.
What is Eurofins Cerep net income for the last year?▼
ZEP1.MU net income for the last year is 4.78M EUR.
How many employees does Eurofins Cerep have?▼
As of November 2, 2026, the company has 209 employees.
In which sector is Eurofins Cerep located?▼
Eurofins Cerep operates in the Health & Wellness sector.
When did Eurofins Cerep complete a stock split?▼
The last stock split for Eurofins Cerep was on July 27, 2017 with a ratio of 1:50.
Where is Eurofins Cerep headquartered?▼
Eurofins Cerep is headquartered in Vienne, France.